TECOS: A Phase III, Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus

Awarded By

  • Merck

Contributors

  • Green, Jennifer Brigitte Investigator and Clinical Lead: Duke Clinical Research Institute Co-Chair: TECOS Operations Committee Chair: TECOS Clinical Events Committee

Start/End

  • 2008